874 / 1224
/
ESTRO SBRT Course 2015 - Emerging SBRT indications
5
• Median OS of 9 – 11 months in metastatic
pancreatic cancer with CT alone
Pancreatic cancer – CT only
FOLFIRINOX
Median 11 months
Conroy NEJM 2011
Nab-Paclitaxel
Von Hoff NEJM 2013
Median 8.5 months